恩宗藥業

0.0600

0.0000

成交量：7.08萬

成交額：4,583.83

市值：445.29萬

市盈率：-0.80

高：0.0680

開：0.0542

低：0.0542

收：0.0600

52周最高：0.1299

52周最低：0.0150

股本：7,421.46萬

流通股本：3,011.40萬

量比：1.01

換手率：0.24%

股息：- -

股息率：- -

每股收益(TTM):-0.0746

每股收益(LYR):-0.0067

淨資產收益率：-7.79%

總資產收益率：-1.88%

市淨率：-1.76

市盈率(LYR):-8.96

資料載入中...

總覽公司新聞資訊公告

恩宗藥業啓動與Viskase合併相關的C系列不可轉換可贖回優先股交換要約

美股速递

·

01/31

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ENZN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ENZN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENZN\",,,,,undefined,":{"symbol":"ENZN","market":"US","secType":"STK","nameCN":"恩宗藥業","latestPrice":0.06,"timestamp":1774036800000,"preClose":0.06,"halted":0,"volume":70787,"delay":15,"changeRate":0,"floatShares":30114014,"shares":74214603,"eps":-0.074553,"marketStatus":"休市中","change":0,"latestTime":"03-20 16:00:00 EDT 延時","open":0.0542,"high":0.068,"low":0.0542,"amount":4583.83,"amplitude":0.23,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.074553,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.06,"volumeRatio":1.0138934627450582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENZN\",,,,,undefined,":{"symbol":"ENZN","floatShares":30114014,"roa":"-1.88%","roe":"-7.79%","lyrEps":-0.006696,"volumeRatio":1.0138934627450582,"shares":74214603,"dividePrice":0,"high":0.068,"amplitude":0.23,"preClose":0.06,"low":0.0542,"week52Low":0.015,"pbRate":"-1.76","week52High":0.1299,"institutionHeld":0,"latestPrice":0.06,"eps":-0.074553,"divideRate":0,"volume":70787,"delay":15,"ttmEps":-0.074553,"open":0.0542,"prevYearClose":0.0379,"prevWeekClose":0.057,"prevMonthClose":0.0601,"prevQuarterClose":0.0379,"fiveDayClose":0.057,"twentyDayClose":0.0652,"sixtyDayClose":0.0441},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENZN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-09-30","symbol":"ENZN","amount":0.12,"name":"恩宗药业","recordDate":"2019-10-15","payableDate":"2019-10-01","currency":"USD","type":"dividend","dateTimestamp":1569816000000},{"market":"US","date":"2019-02-20","symbol":"ENZN","amount":0.06,"name":"恩宗药业","recordDate":"2019-03-21","payableDate":"2019-02-21","currency":"USD","type":"dividend","dateTimestamp":1550638800000},{"market":"US","date":"2017-09-29","symbol":"ENZN","amount":0.15,"name":"恩宗药业","recordDate":"2017-09-28","payableDate":"2017-08-30","currency":"USD","type":"dividend","dateTimestamp":1506657600000},{"market":"US","date":"2016-12-30","symbol":"ENZN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1483074000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENZN\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-13","recordDate":"2016-11-28","paymentDate":"2016-12-12","value":0.15,"currency":"USD"},{"executeDate":"2017-09-29","recordDate":"2017-08-30","paymentDate":"2017-09-28","value":0.15,"currency":"USD"},{"executeDate":"2019-02-20","recordDate":"2019-02-21","paymentDate":"2019-03-21","value":0.06,"currency":"USD"},{"executeDate":"2019-09-30","recordDate":"2019-10-01","paymentDate":"2019-10-15","value":0.12,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENZN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENZN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1100588637","title":"恩宗藥業啓動與Viskase合併相關的C系列不可轉換可贖回優先股交換要約","url":"https://stock-news.laohu8.com/highlight/detail?id=1100588637","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100588637?lang=zh_tw&edition=fundamental","pubTime":"2026-01-31 06:16","pubTimestamp":1769811375,"startTime":"0","endTime":"0","summary":"恩宗药业（Enzon Pharmaceuticals, Inc.）宣布，正式启动与Viskase公司合并计划相关的C系列不可转换可赎回优先股交换要约。此举标志着两家企业整合进程进入关键阶段，旨在优化资本结构并为合并后的新实体奠定财务基础。\n此次交换要约涉及特定类别的优先股置换安排，将直接影响股东权益配置。公司表示，该操作符合战略重组目标，旨在提升长期价值创造能力。交易细节将根据监管要求及时披露，确保股东享有充分知情权与参与权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENZN"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}